Table of Contents

• 1.1 List of Tables 15
• 1.2 List of Figures 24

2 Introduction 25

• 2.1 Lung Cancer Diagnostic Tests Overview 25

3 Products under Development 26

• 3.1 Lung Cancer Diagnostic Tests - Pipeline Products by Stage of Development 26
• 3.2 Lung Cancer Diagnostic Tests - Pipeline Products by Territory 27
• 3.3 Lung Cancer Diagnostic Tests - Pipeline Products by Regulatory Path 28
• 3.4 Lung Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date 29
• 3.5 Lung Cancer Diagnostic Tests - Ongoing Clinical Trials 30

4 Lung Cancer Diagnostic Tests - Pipeline Products under Development by Companies 31

• 4.1 Lung Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development 31
• 4.2 Lung Cancer Diagnostic Tests - Pipeline Products by Stage of Development 36

5 Lung Cancer Diagnostic Tests Companies and Product Overview 41

6 Lung Cancer Diagnostic Tests - Recent Developments 220

7 Appendix 540

Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Lung Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Lung Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Lung Cancer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Lung Cancer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Lung Cancer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date